Cardiovascular risk and treatment for adults with intellectual or developmental disabilities

Steven R Erickson1, Patrick Spoutz2, Michael Dorsch1

  • 1University of Michigan College of Pharmacy, Department of Pharmacy Practice, United States.

Insights

Cardiovascular disease risk factors and treatments are similar for individuals with intellectual/developmental disabilities (IDDs) compared to the general population. This study found comparable risk diagnoses and prescribing patterns between groups.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Individuals with intellectual/developmental disabilities (IDDs) experience cardiovascular disease (CVD) risk comparable to the general population.
  • Understanding CVD risk factors and management in IDD populations is crucial for equitable healthcare.
  • Existing research often overlooks specific cardiovascular risk profiles within the IDD community.

Purpose of the Study:

  • To compare cardiovascular disease (CVD) risk factors, atherosclerotic cardiovascular (ASCVD) risk scores, and medication prescribing patterns.
  • To evaluate these factors in patients with IDDs versus those without IDDs.
  • To inform clinical practice and public health strategies for CVD prevention in IDD populations.

Main Methods:

  • Retrospective study of adult primary care patients within a health system.
  • Comparison of an IDD group (n=78) with a general medicine (GenMed) comparison group (n=187).
  • Analysis included demographics, smoking status, cholesterol, blood pressure, CVD diagnoses, and medication use; estimated 10-year ASCVD risk was the primary outcome.

Main Results:

  • No significant differences were found in the prevalence of CVD risk diagnoses, blood pressure, or cholesterol levels between the IDD and GenMed groups.
  • The estimated 10-year ASCVD risk was significantly higher in the GenMed group (p=0.02).
  • Medication prescribing patterns were similar between groups; regression analysis indicated age, gender, and race, not group assignment, were significantly associated with ASCVD risk.

Conclusions:

  • Cardiovascular risk and related treatment in patients with IDDs are similar to the general population.
  • This suggests that current general CVD risk management strategies may be applicable to individuals with IDDs.
  • Further research could explore specific barriers or facilitators to CVD care within the IDD population.
Abstract

Related Concept Videos

Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
987
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
813
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
503
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
553
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584